Mahesh C. Patra
Suwon, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Time-Resolved Transcriptomic Profiling of Surgical Wounds Identifies Stage-Specific Therapeutic Targets for Residual Ovarian Cancer.
Journal: Pharmaceutics
Published: February 02, 2026
Rational design and therapeutic potential of MyD88 inhibitory peptide in psoriasis.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: October 02, 2024
Discovery of Novel Small Molecule Dual Inhibitor Targeting Toll-Like Receptors 7 and 9.
Journal: Journal of chemical information and modeling
Published: June 21, 2024
Decoy peptides that inhibit TNF signaling by disrupting the TNF homotrimeric oligomer.
Journal: The FEBS journal
Published: March 26, 2023
An orally active, small-molecule TNF inhibitor that disrupts the homotrimerization interface improves inflammatory arthritis in mice.
Journal: Science signaling
Published: November 08, 2022
MLCPP 2.0: An Updated Cell-penetrating Peptides and Their Uptake Efficiency Predictor.
Journal: Journal of molecular biology
Published: November 30, 2021
A Rational Insight into the Effect of Dimethyl Sulfoxide on TNF-α Activity.
Journal: International journal of molecular sciences
Published: November 21, 2020
A Computational Probe into the Structure and Dynamics of the Full-Length Toll-Like Receptor 3 in a Phospholipid Bilayer.
Journal: International journal of molecular sciences
Published: March 16, 2020
A Novel Small-Molecule Inhibitor of Endosomal TLRs Reduces Inflammation and Alleviates Autoimmune Disease Symptoms in Murine Models.
Journal: Cells
Published: February 15, 2020
A peptide derived from the core β-sheet region of TIRAP decoys TLR4 and reduces inflammatory and autoimmune symptoms in murine models.
Journal: EBioMedicine
Published: May 03, 2019
A cell-penetrating peptide blocks Toll-like receptor-mediated downstream signaling and ameliorates autoimmune and inflammatory diseases in mice.
Journal: Experimental & molecular medicine
Published: February 07, 2019
Toll-like receptor-induced cytokines as immunotherapeutic targets in cancers and autoimmune diseases.
Journal: Seminars in cancer biology
Published: January 13, 2019
Last Updated: 09/26/2026